✦ LIBER ✦

The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole

✍ Scribed by Barreto, Jason N.; Beach, Cassidy L.; Wolf, Robert C.; Merten, Julianna A.; Tosh, Pritish K.; Wilson, John W.; Hogan, William J.; Litzow, Mark R.

Book ID: 120434445
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 145 KB
Volume: 88
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23388

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patterns of Infection in Patients With M

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

✍ Falantes, Jose F.; Calderón, Cristina; Márquez-Malaver, Francisco J.; Aguilar-Gu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 291 KB

Amphotericin B lipid complex as prophyla

Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy

✍ Gloria N. Mattiuzzi; Hagop Kantarjian; Stefan Faderl; JoAnn Lim; Dimitrios Konto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## BACKGROUND The optimal antifungal prophylactic regimen for patients with acute myelogenous leukemia (AML) or high‐risk myelodysplastic syndrome (MDS) undergoing induction chemotherapy has yet to be identified. A prospective historical control study evaluated the efficacy and safety

O-021 Patterns of infection in patients

O-021 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis

✍ Falantes, J.; Calderón, C.; Márquez-Malaver, F.J.; Aguilar, M.; Martino, M.L.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy and safety of intravenous voric

Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

✍ Gloria N. Mattiuzzi; Jorge Cortes; Gladys Alvarado; Srdan Verstovsek; Charles Ko 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 139 KB

Incidence Density of Invasive Fungal Inf

Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011

✍ Gomes, M. Z. R.; Mulanovich, V. E.; Jiang, Y.; Lewis, R. E.; Kontoyiannis, D. P. 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 759 KB

A multicenter, randomized trial of posac

A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs) in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) receiving intensive chemotherapy

✍ D.J. Winston; O.A. Cornely; J. Maertens; J. Perfect; D. Helfgott; A.J. Ullmann; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB